Analyst Ratings for BlossomHill Therapeutics (BLSM)

BLSM Rating Summary

BLSM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BLSM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $31.25 (+64.6%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/1/2026 LifeSci Capital N/A New Coverage Outperform
(N/A)
32.00
(N/A)
18.30
(18.99)
3.77% Details
9/1/2026 H.C. Wainwright Robert Burns New Coverage Buy
(N/A)
35.00
(N/A)
18.30
(18.99)
3.77% Details